Christopher P. Filson
Papers
1
Total Citations
2
H-Index
1
About
Christopher P. Filson is a health services researcher and urologic oncologist whose work sits at the intersection of surgical practice, health policy, and patient outcomes. His research focuses on how changes in Medicare reimbursement and regulatory frameworks influence the adoption and delivery of surgical procedures, particularly in prostate cancer care. A key contribution is his 2022 study on trends in urethral suspension during robotic prostatectomy following Medicare payment policy changes. This work demonstrated that when the Centers for Medicare and Medicaid Services reduced reimbursement for robotic prostatectomy in 2016, and tightened billing rules for urethral suspension—requiring preexisting incontinence for coverage—surgeons altered their practice patterns. Filson’s analysis revealed a measurable decline in the use of urethral suspension, highlighting how financial incentives can shape clinical decision-making. Though his most-cited paper has garnered 2 citations to date, its policy relevance is significant, offering real-world evidence of how payment reforms affect surgical care. His broader portfolio examines the intersection of urologic oncology, health economics, and quality improvement, making his work essential reading for researchers and clinicians navigating the evolving landscape of value-based care.
Research Focus
Key Achievements
Top Papers
- 1